About TROCAR PHARMA INC.
Trocar Pharma is a biotechnology company focused on developing therapeutics to counteract cellular damage and increase human longevity, with a specific emphasis on treating GI Acute Radiation Syndrome and enhancing survival after exposure to lethal radiation doses.
Tissue-targeted platform technology to counteract reactive oxygen species (ROS)In vivo studies confirming efficacy in regenerating stem cells and increasing lifespanDevelopment of proprietary small molecule therapeuticsFocus on GI Acute Radiation Syndrome (GI ARS) treatmentPartnerships with universities and participation in DoD/NIAID-sponsored studies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TROCAR PHARMA INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.